Stroke is one of the leading causes of disability in Europe. Central and Eastern European countries have the highest incidence and mortality rates through Europe. The improvements in stroke prevention and treatment in Central and Eastern European countries did not completely reach the quality parameters present in Western European countries. We present features of current management of stroke in Central and Eastern European countries.
FeiginVL, ForouzanfarMH, KrishnamurthiR. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.Lancet2014; 383: 245–54.
2.
KrishnamurthiRV, FeiginVL, ForouzanfarMH. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.Lancet Glob Health2013; 1: e259–81.
3.
LentiL, BraininM, TitianovaE. Stroke care in Central Eastern Europe: current problems and call for action.Int J Stroke2013; 8: 365–71.
4.
CzlonkowskaA, SkowronskaM, NiewadaM. Stroke service in Central and Eastern Europe.Int J Stroke2007; 2: 276–8.
5.
BraininM, BornsteinN, BoysenG, DemarinV. Acute neurological stroke care in Europe: results of the European Stroke Care Inventory.Eur J Neurol2000; 7: 5–10.
6.
StegmayrB, AsplundK, KuulasmaaK, RajakangasAM, ThorvaldsenP, TuomilehtoJ. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations.Stroke1997; 28: 1367–74.
7.
ThorvaldsenP, KuulasmaaK, RajakangasAM, RastenyteD, SartiC, WilhelmsenL. Stroke trends in the WHO MONICA Project.Stroke1997; 28: 500–6.
8.
PajakAK, KozelaM. Cardiovascular disease in Central and East Europe.Public Health Rev2012; 33: 416–35.
9.
KarlinskiM, KobayashiA, MikulikR, SanakD, WahlgrenN, CzlonkowskaA. Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe.Int J Stroke2012; 7: 615–22.
